Keybank National Association Gilead Sciences, Inc. Transaction History

Keybank National Association

$25.5 Billion
Q3 2024

A detailed history of Keybank National Association transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Keybank National Association holds 115,794 shares of GILD stock, worth $10.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

115,794

Previous 115,970 0.15%

Holding current value

$10.9 Million

Previous $7.96 Million 21.98%

% of portfolio

0.04%

Previous 0.03%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$66.59 - $83.99 $11,719 - $14,782	-176 Reduced 0.15%	115,794 $9.71 Million
Q2 2024 Jul 31, 2024	SELL	$63.15 - $72.88 $348,714 - $402,443	-5,522 Reduced 4.55%	115,970 $7.96 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $383,955 - $468,223	5,364 Added 4.62%	121,492 $8.9 Million
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $865,538 - $981,542	11,813 Added 11.32%	116,128 $9.41 Million
Q3 2023 Nov 08, 2023	SELL	$73.94 - $80.67 $210,137 - $229,264	-2,842 Reduced 2.65%	104,315 $7.82 Million
Q2 2023 Aug 01, 2023	SELL	$76.01 - $86.7 $92,352 - $105,340	-1,215 Reduced 1.12%	107,157 $8.26 Million
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $27,445 - $31,268	-355 Reduced 0.33%	108,372 $8.99 Million
Q4 2022 Jan 31, 2023	BUY	$62.32 - $89.47 $287,731 - $413,082	4,617 Added 4.43%	108,727 $9.33 Million
Q3 2022 Oct 27, 2022	SELL	$59.54 - $68.01 $220,833 - $252,249	-3,709 Reduced 3.44%	104,110 $6.42 Million
Q2 2022 Aug 08, 2022	SELL	$57.72 - $65.01 $72,438 - $81,587	-1,255 Reduced 1.15%	107,819 $6.66 Million
Q1 2022 Apr 28, 2022	SELL	$57.92 - $72.58 $265,563 - $332,779	-4,585 Reduced 4.03%	109,074 $6.48 Million
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $447,866 - $508,336	-6,903 Reduced 5.73%	113,659 $8.25 Million
Q3 2021 Nov 08, 2021	SELL	$67.69 - $73.03 $309,884 - $334,331	-4,578 Reduced 3.66%	120,562 $8.42 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $679,319 - $742,253	-10,703 Reduced 7.88%	125,140 $8.62 Million
Q1 2021 May 07, 2021	SELL	$60.0 - $68.46 $594,540 - $678,370	-9,909 Reduced 6.8%	135,843 $8.78 Million
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $784,999 - $894,469	-13,857 Reduced 8.68%	145,752 $8.49 Million
Q3 2020 Oct 29, 2020	SELL	$62.1 - $78.08 $594,421 - $747,381	-9,572 Reduced 5.66%	159,609 $10.1 Million
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $58,233 - $67,620	-805 Reduced 0.47%	169,181 $13 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $786,444 - $1.01 Million	-12,557 Reduced 6.88%	169,986 $12.7 Million
Q4 2019 Feb 05, 2020	SELL	$61.62 - $67.78 $1.33 Million - $1.46 Million	-21,533 Reduced 10.55%	182,543 $11.9 Million
Q3 2019 Nov 04, 2019	SELL	$62.51 - $69.0 $1.66 Million - $1.83 Million	-26,511 Reduced 11.5%	204,076 $12.9 Million
Q2 2019 Aug 01, 2019	SELL	$61.87 - $69.38 $2.6 Million - $2.92 Million	-42,045 Reduced 15.42%	230,587 $15.6 Million
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $3.8 Million - $4.26 Million	-60,780 Reduced 18.23%	272,632 $17.7 Million
Q4 2018 Jan 30, 2019	SELL	$60.54 - $79.0 $10.7 Million - $14 Million	-176,705 Reduced 34.64%	333,412 $20.9 Million
Q3 2018 Nov 08, 2018	BUY	$71.28 - $78.92 $540,587 - $598,529	7,584 Added 1.51%	510,117 $39.4 Million
Q2 2018 Aug 08, 2018	SELL	$64.88 - $75.68 $61,571 - $71,820	-949 Reduced 0.19%	502,533 $35.6 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $651,262 - $793,960	8,941 Added 1.81%	503,482 $38 Million
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $2.87 Million - $3.37 Million	-40,294 Reduced 7.53%	494,541 $35.4 Million
Q3 2017 Nov 02, 2017	SELL	$72.11 - $85.47 $498,496 - $590,854	-6,913 Reduced 1.28%	534,835 $43.3 Million
Q2 2017 May 14, 2018	SELL	N/A	-59,637 Reduced 9.92%	541,748 $38.3 Million
Q1 2017 May 14, 2018	SELL	N/A	-59,387 Reduced 8.99%	601,385 $40.8 Million
Q4 2016 May 14, 2018	BUY	N/A	660,772	660,772 $47.3 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Account

Keybank National Association Gilead Sciences, Inc. Transaction History